Bruker BRKR Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Business | ||||||
| Bsi Biospin | $868.5M-6.7% | $878.8M-3.0% | $884.2M— | $908.5M— | $930.7M— | |
| Bsi Calid | $1.25B+8.8% | $1.21B+10.7% | $1.2B— | $1.17B— | $1.15B— | |
| Bsi Nano | $1.07B-3.7% | $1.08B-1.3% | $1.09B— | $1.11B— | $1.11B— | |
| Energy And Supercon Technologies | $278.4M+3.4% | $270.9M-4.3% | $271.5M-5.1% | $266.4M-7.5% | $269.2M-7.7% | |
| Cost Of Segment Revenue by Business | ||||||
| Bsi Biospin | $458.9M+0.1% | $465.9M+6.4% | $453.3M+11.3% | $455.6M+17.6% | $458.3M+23.8% | |
| Bsi Calid | $546.7M+11.7% | $525.2M+12.8% | $512.3M+20.4% | $503.5M+25.3% | $489.4M+25.9% | |
| Bsi Nano | $525.3M+0.3% | $524M+1.0% | $522.6M+9.1% | $529.6M+16.9% | $523.8M+18.3% | |
| Energy And Supercon Technologies | $224.6M+6.7% | $218.5M-1.8% | $216.6M-2.2% | $210.7M-5.7% | $210.4M-7.7% | |
| Operating Income by Business | ||||||
| Bsi Biospin | $148.2M-32.4% | $156.5M-27.7% | $172.1M-23.7% | $195.6M-11.6% | $219.1M+10.4% | |
| Bsi Calid | $263.6M+2.7% | $262.5M+6.6% | $268.8M+8.1% | $251.5M+4.8% | $256.6M+13.7% | |
| Bsi Nano | $92.4M-21.0% | $101.1M-18.3% | $100.1M-27.6% | $107.2M-26.9% | $117M-26.3% | |
| Energy And Supercon Technologies | $27.3M-19.5% | $26.7M-23.9% | $29.8M-3.6% | $30.5M-5.3% | $33.9M+3.7% | |
| Selling General And Administrative Expense by Business | ||||||
| Bsi Biospin | $165.5M+2.9% | $162.7M+2.4% | $165.1M+11.0% | $163.5M+14.6% | $160.9M+16.6% | |
| Bsi Calid | $311.2M+9.1% | $302.8M+12.1% | $299.1M+16.7% | $293.3M+19.2% | $285.3M+20.5% | |
| Bsi Nano | $283.2M-4.7% | $284M-2.4% | $291.8M+8.8% | $298.1M+19.8% | $297.2M+27.0% | |
| Energy And Supercon Technologies | $22.9M+8.5% | $22.3M+3.7% | $21.8M+3.2% | $21.6M+5.1% | $21.1M+4.6% | |
| Total Assets by Business | ||||||
| BSI Bio Spin CALIDNANO And Corporate | $24.55B— | $24.34B— | $23.9B— | —— | —— | |
| Energy And Supercon Technologies | $769.6M-1.6% | $779.8M+3.0% | $787.2M+5.9% | $793.8M+11.1% | $782M+11.4% | |
| Segment Expenditure Addition To Long Lived Assets by Business | ||||||
| Bsi Biospin | $10.6M-59.8% | $11.4M-50.0% | $16.3M-28.4% | $24.9M+62.2% | $26.4M+50.6% | |
| Bsi Calid | $23.6M-36.4% | $25.3M-25.6% | $36.8M+41.3% | $36.2M+32.1% | $37.1M+28.6% | |
| Bsi Nano | $36.5M+102% | $36.5M+88.1% | $26.1M+45.2% | $27.3M+59.2% | $18.1M+8.9% | |
| Corporate | $13.6M-18.1% | $16M+9.6% | $16.8M+24.9% | $19.5M+65.3% | $16.6M+60.4% | |
| Energy And Supercon Technologies | $10.6M-50.9% | $13.8M-43.4% | $15.6M-37.5% | $17.7M-36.0% | $21.6M-23.5% | |
| Research And Development Expense by Business | ||||||
| Bsi Biospin | $95.9M+3.8% | $93.7M+1.3% | $93.6M+8.4% | $93.8M+13.3% | $92.4M+14.9% | |
| Bsi Calid | $124.9M+9.2% | $119.7M+7.2% | $119M+13.3% | $117.6M+17.4% | $114.4M+17.3% | |
| Bsi Nano | $172.8M-2.1% | $175.2M+6.3% | $179M+20.2% | $179.2M+33.8% | $176.5M+45.2% | |
| Energy And Supercon Technologies | $3.6M-5.3% | $3.4M-12.8% | $3.3M-12.0% | $3.6M+2.9% | $3.8M+28.8% | |
| Restructuring Charges by Business | ||||||
| Bsi Biospin | $6.1M-17.6% | $9M+463% | $5.7M+212% | $4.7M+348% | $7.4M+480% | |
| Bsi Calid | $20M+388% | $19.7M+579% | $17.3M+776% | $5.5M+214% | $4.1M+188% | |
| Bsi Nano | $20.5M+181% | $13M+27.5% | $11M-11.3% | $7M-52.7% | $7.3M-49.7% | |
| Corporate | $3.4M— | $3.2M+540% | $1.1M+57.1% | $1.2M+33.3% | $0-100% | |
| D&A by Business | ||||||
| Bsi Biospin | $44.5M+3.0% | $43.2M+5.4% | $43.3M+20.9% | $44M+39.9% | $43.2M+57.2% | |
| Bsi Calid | $97.1M+25.9% | $92.3M+37.6% | $90M+74.3% | $85.1M+114% | $77.1M+143% | |
| Bsi Nano | $67.5M+3.8% | $67.2M+8.9% | $65.8M+12.3% | $66.2M+24.2% | $65M+31.6% | |
| Corporate | $9.2M+64.3% | $8.2M+49.1% | $7M+32.7% | $6.3M+27.3% | $5.6M+16.1% | |
| Energy And Supercon Technologies | $9.9M+16.5% | $9.4M+11.9% | $9M+9.8% | $8.8M+14.3% | $8.5M+14.9% | |
| Revenue by Product | ||||||
| Product And Service Other | $689M+9.3% | $670.1M+10.4% | $661.2M+15.0% | $646.9M+18.2% | $630.5M+20.4% | |
| Product | $2.77B-1.6% | $2.77B+0.3% | $2.78B+4.2% | $2.8B+8.7% | $2.82B+13.7% | |
| Cost Of Revenue by Product | ||||||
| Product And Service Other | $380.4M+4.8% | $372.3M+5.6% | $362.2M+4.8% | $366.4M+15.8% | $363.1M+23.2% | |
| Product | $1.51B+8.4% | $1.49B+8.9% | $1.45B+11.1% | $1.42B+13.0% | $1.4B+16.3% | |
| Revenue by Geography | ||||||
| Asia Pacific Excluding China | $555.9M+2.4% | $552.6M+6.6% | $553.7M+17.9% | $564.1M+27.1% | $542.9M+19.9% | |
| CN | $448.6M-1.8% | $475.8M+1.0% | $451.5M-14.0% | $451M-16.5% | $456.7M-14.8% | |
| DE | $298.6M-2.1% | $297M-4.4% | $277.6M-8.7% | $280.6M-8.8% | $305M+6.8% | |
| Europe Excluding Germany | $985M+7.2% | $950.2M+8.8% | $965.7M+26.9% | $940.1M+30.5% | $919M+30.7% | |
| Other Country | $274.6M+5.0% | $269.6M+5.9% | $263.1M+5.7% | $266.7M+17.9% | $261.4M+14.5% | |
| US | $895.8M-6.8% | $891.3M-5.0% | $927.3M+4.2% | $940.3M+9.1% | $961.1M+20.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Bruker break its business down?
- Bruker (BRKR) reports revenue by business across 4 parts — Bsi Biospin, Bsi Calid, Bsi Nano and Energy And Supercon Technologies. Each is extracted from the segment footnotes and tracked over time.
- Where does Bruker's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Bruker's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
